Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Glysious ApS
APS
Active
CVR 41845619
Kong Valdemars Vej 58, 2840
Holte
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2020 · 5 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Glysious ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Gross profit
240
405
267
620
Staff expenses
-95
-206
-200
-222
EBITDA
145
199
67
398
Depreciation & amort.
-0
-0
-0
-86
EBIT
145
199
67
312
Net financials
-13
-16
-13
-10
Profit before tax
131
182
53
302
Tax
15
20
9
63
Net profit
116
163
45
240
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
576
734
1.102
1.114
Equity
212
374
419
658
Long-term debt
0
0
0
0
Short-term debt
358
341
656
391
Total debt
358
341
656
391
Financial ratios
5-year trend
EBITDA margin (of gross profit)
64.2%
This company
2022
2025
Equity ratio
59.1%
This company
38.2%
Market median
+55% vs market
2022
2025
Return on equity
36.4%
This company
18.4%
Market median
+98% vs market
2022
2025
Net profit margin (of gross profit)
38.6%
This company
2022
2025
Asset turnover (of gross profit)
0.56×
This company
2022
2025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2020-11-12 – 2022-03-31
View
PDF
More on Glysious ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
